Why the study?
Do non-medicated patients with schizophrenia have altered heart rate, respiration, and cardiorespiratory coupling compared to healthy controls?
Do non-medicated patients with schizophrenia have altered heart rate, respiration, and cardiorespiratory coupling compared to healthy controls?
Non-medicated patients with schizophrenia exhibit altered cardiorespiratory coupling and autonomic regulation, which may contribute to their increased risk of cardiovascular mortality.
Answers are grounded in this paper and cite their sources.
Altered cardiorespiratory complexity may signal autonomic dysregulation linked to cardiovascular mortality in schizophrenia; leaves open causal and prognostic value.
Schizophrenia is a severe mental disorder associated with a significantly increased cardiovascular mortality rate. However, the underlying mechanisms leading to this cardiovascular disease (CVD) are not fully known. Therefore, the objective of this study was to characterize the cardiorespiratory influence by investigating heart rate, respiration and the causal strength and direction of cardiorespiratory coupling (CRC), based mainly on entropy measures. We investigated 23 non-medicated patients with schizophrenia (SZ), comparing them to 23 age- and gender-matched healthy controls (CO). A significantly reduced complexity was found for the heart rate and a significantly increased complexity in respiration and CRC in SZ patients when compared to corresponding measurements from CO (p < 0.001). CRC analyses revealed a clear coupling, with a driver-responder relationship from respiration to heart rate in SZ patients. Moreover, a slight driver-responder relationship from heart rate to respiration could be recognized. These findings lead to the assumption that SZ should be considered to be a high-risk group for CVD. We hypothesize that the varying cardiorespiratory regulation contributes to the increased risk for cardiac mortality. Therefore, regular monitoring of the cardiorespiratory status of SZ is suggested to identify autonomic regulation impairment at an early stage—to develop timely and effective treatment and intervention strategies.
No takes yet. Share an insight, caveat, or question.
Schulz et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: